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To u n d e r s t a n d t h e immunologic m e c h a n i s m underlying e a r l y ( ( 7 d a y ) 'vaccine f a i l u r e ' a f t e r a d m i n i s t r a t i o n of t h e Hi c a p s u l a r p o l y s a c c h a r i d e v a c c i n e (HiPV),we u s e d t h e infant r a t model t o e v a l u a t e w h e t h e r HiPV m i g h t , f o r a s h o r t p e r i o d , d e c r e a s e t h e p r o t e c t i o n a f f o r d e d by a n t i c a p s u l a r antibody (ACA). 7 4 five d a y old infant r a t s w e r e p a s s i v e l y p r o t e c t e d with b a c t e r i a l p o l y s a c c h a r i d e i m m u n e globulin (BPIG) p r e p a r e d f r o m a d u l t s immunized with HiPV.
One d a y l a t e r , t h e m e a n ACA c o n c e n t r a t i o n w a s 173 i 8 5 ng/ml. The pups w e r e immunized 2 4 h o u r s a f t e r BPIG with e i t h e r 75 o r 7500 ng HiPV.The l o w e r HiPV d o s e w a s e x t r a p o l a t e d f r o m t h a t c u r r e n t l y r e c o m m e n d e d f o r i n f a n t s . C o n t r o l s w e r e given IG a l o n e o r HiPV 85 a l o n e . All a n i m a l s w e r e c h a l l e n g e d ip with 5x10 c f u HI t y p e b o n e d a y a f t e r immunization. Detectable b a c t e r e m i a and meningitis w e r e m o r e f r e q u e n t in HiPV immunized BPIG r e c i p i e n t s t h a n in unimmunized BPIG r e c i p i e n t s (100% v s 181, pc.00001 f o r b a c t e r e m i a and 100% v s 181, pc.00001 f o r meningitis). A l s o , i n b a c t e r e m i c a n i m a l s , t h e magnitude of b a c t e r e m i a in t h e BPIG/HiPV r cipie s e x c e e d e d t h a t in BPIG p r o t e c t e d , non-HiPV r e c i p i e n t s ( 1 0 4 m 8 v s 10y.l, p = . 0 0 0 5 ) . HiPV a d m i n i s t r a t i o n did not d e p l e t e c o m p l e m e n t . However, a n i m a l s given BPlG followed by HiPV had l o w e r m e a n ACA c o n c e n t r a t i o n s t h a n a n i m a l s receiving BPIG a l o n e ( 2 9 v s 151 n g / m l , p < . 0 1 ) . M o r e o v e r , ACA w a s u n d e t e c t a b l e ( < 25 n g / m l ) in 18/20 BPIG/HiPV r e c i p i e n t s . We We have previously shown t h a t herpes simplex virus (HSV) glycopro tein vaccines administered prior to viral challenge p r o t e c t animals from initial herpetic disease a s well a s re&ce t h e incidence of subsequent recurrent infections. We hypothesized t h a t control of r e c u r r e n t genital herpes in animals with established l a t e n t HSV infection might b e achieved through t h e administration of HSV glycoprotein vaccines a f t e r recovery from initial infection. In a n initial e x p e r i m e n t Hartley guinea pigs were intravaginally inoculated with 5.7 log 10 pfu HSV-2 MS strain and t r e a t e d with acyclovir in drinking water for 10 days. Half t h e animals were treated on days 1 8 and 40 with hind footpad administration of a lentil lectin purified mixture of HSV-2 glycoproteins (gP-2) derived from infected Vero cells. T h e t r e a t e d animals had significantly fewer (p c.05) and less severe (p c.001) episodes of recurrent disease t h e n t h e unimmunized controls. In a second experiment, animals were immunized o n days 21 and 42 with e i t h e r gP-2 or a mixture of genetically engineered HSV-I glycoprotein 6 and D. T h e recombinant vaccine was a s I n a c t i v a t e d i n f l u e n z a v a c c i n e s c o n f e r incomplete and t r a n s i e n t p
r o t e c t i o n from d i s e a s e , and t h e whole-virus i n a c t i v a t e d v a c c i n e s cause h i g h r a t e s o f r e a c t i o n s i n c h i l d r e n . L i v e , a t t e n u a t e d v a c c i n e s have been developed from c o l d -a d a p t e d
(CA) and avian-human (AH) i n f l u e n z a v i r u s r e a s s o r t a n t s , and a r e s a f e and e f f e c t i v e i n a d u l t s . We compared t h e i n f e c t i o u s d o s e 0 , immunogenici t y , r e a c t o g e n i c i t y and t r a n s m i s s a b i l i t y o? CA and A H i n f l u e n z a A/Bethesda/85 (H3N2) r e a s s o r t a n t v a c c i n e s i n young c h i l d r e n . T h e r e were no d i f f e r e n c e s i n r a t e s o f f e b r i l e o r r e s p i r a t o r y i l l n e s s between v a c c i n e e s and p l a c e b o r e c i p i e n t s .
Vaccine v i r u s was shed i n low t i t e r s ( 5 . 6 t o 27.5 TCID O/ml) f o r 1 t o 5 days by v a c c i n e e s , and no t r a n s m i s s i o n t o p?acebo c o n t a c t s o c c u r r e d . Both v a c c i n e s a p p e a r t o be s a f e and immunogenic i n young c h i l d r e n and i n f a n t s .
COMPARISON OF LATEX AGGLUTINATION AND ELISA MONO-CLONAL ANTIBODY ASSAYS FOR DETECTION OF HUMAN ROTA-VIRUS (HRV). C a r o l S t o u t , Robin R o b e r t s and M. Dianne 970 Murphy. U n i v e r s i t y o f Tennessee H o s p i t a l , Dept. o f P e d i a t r i c s , K n o x v i l l e , TN. Spons.: J i m Todd. M.D. R o t a v i r u s i s a n i m p o r t a n t -c a u s e o f c h i l d h o o d g a s t r o e n t e r i t i s r e s u l t i n g i n d e h y d r a t i o n , h o s p i t a l a d m i s s i o n and nosocomial i n f e c t i o n s . F a l s e n e g a t i v e a n t i g e n t e s t s may l e a d t o f u r t h e r u n n e c e s s a r y d i a g n o s t i c t e s t s and t h e r a p y .
We compared a l a t e x a g g l u t i n a t i o n a s s a y ( R o t a l e x ; Medical Technology Corp.) w i t h a n ELISA p r o c e d u r e ( P a t h f i n d e r ; K a l l e s t a d L a b o r a t o r i e s ) f o r t h e d i a g n o s i s o f HRV. The l a t e x a g g l u t i n a t i o n t e s t used f r e s h s t o o l suspended i n 1 0 m l ' s o f b u f f e r which was mixed w i t h r e a c t i v e and n o n -r e a c t i v e l a t e x p a r t i c l e s f o r 2 m i n u t e s and obs e r v e d f o r a g g l u t i n a t i o n . The 1 112 hour d i r e c t ELISA u t i l i z e d d i l u t e d s t o o l mixed w i t h a monoclonal a n t i b o d y and added t o t u b e s p r e c o a t e d w i t h a n t i b o d y . Both a s s a y s were v i s u a l l y i n t e rp r e t e d . From 11/85 t o 4/86, 109 s t o o l specimens were t e s t e d by b o t h methods; 1 5 (14%) were R o t a l e x (+) f o r HRV and 48 (44%) were ELISA (+) f o r HRV. T h i r t y -f i v e specimens were ELISA (+)I R o t a l e x (-). Of t h e s e , 22 o f 30 a v a i l a b l e specimens were conf i r m e d by a b l o c k i n g a s s a y a s t r u e p o s i t i v e s . S e n s i t i v i t y and s p e c i f i c i t y of P.otalex was 37% and 98%, r e s p e c t i v e l y , when compared w i t h t h e confirmed ELISA. The R o t a l e x l a t e x a s s a y a p p e a r s t o be l e s s s e n s i t i v e t h a n t h e P a t h f i n d e r ELISA a s s a y f o r d e t e c ti n g HRV. The b e n e f i t s o f t h e v e r y r a p i d l a t e x t e s t must be weighed a g a i n s t i t s i n s e n s i t i v i t y .
The l a t e x t e s t may b e s t be used a s a s c r e e n i n g p r o c e d u r e . Long Beach C i p r o f l o x a c i n (c) is a new q u i n o l o n e a n t i m i c r o b i a l w i t h a broad spectrurm o f a c t i v i t y and o r a l bioavailability that may be u s e f u l f o r the t h e r a p y o f s y s t e m i c i n f e c t i o n s i n children. F h a n m w k i n e t i c s , CSF penetration and e f f i c a c y of this agent were studied i n an i n f a n t rabbit model o f Serum c o n c e n t r a t i o n s (conc.) peaked 1-3 h a f t e r oral doshg and b i o a v a i l a b i l i t y (AUC p/AUC i v ) was 40.5%. R a b b i t s w i t h H i b meningitis w e r e given C 5 0 w / k g p q12h. Peak serum conc. (3.321.5) and T i (3.0 h ) w e r e s i m i l a r t o u n i n f e d e d a n i m a l s , but CSF conc. w e r e h i g h e r (mean 0.14 ug/ml, p e n e t r a t i o n 7.8_+1.6%). Serum wnc. 1 2 h a f t e r an o r a l dose (0.16 ug/ml) w e r e still 10X the H i b MIC. CSF cultures showed 2500 cfu/ml b e f o r e and 1 6 cfu/ml 2 h a f t e r treatment. CSF cultures a t 6 h w e r e sterile. C w a r r a n t s further s t u d y in the t r e a t m e n t o f systemic I f i b i n f e c t i o n s .
R e s p i r a t o r y s y n c y t i a l v i r u s (RSV) i s a n i m p o r t a n t c a u s e o f r e s p i r a t o r y d i s e a s e i n young c h i l d r e n . We e v a l u a t e d a c e n t r if u g a t i o n c u l t u r e t e c h n i q u e ' s a b i l i t y t o p r o v i d e r a p i d c u l t u r e d i a g n o s i s . Between 11/85 & 3/86, 365 r e s p i r a t o r y specimens were p r o c e s s e d by s t a n d a r d c u l t u r e & / o r d i r e c t immunofluorescent a n t ibody (FA). Of t h e s e , 183 specimens (74% n a s a l washes) were inoc u l a t e d w i t h 0 . 2 ml o n t o HEp-

